ATE529440T1 - Biologisch aktives peptid und wirkstoff, der dieses enthält - Google Patents
Biologisch aktives peptid und wirkstoff, der dieses enthältInfo
- Publication number
- ATE529440T1 ATE529440T1 AT08006914T AT08006914T ATE529440T1 AT E529440 T1 ATE529440 T1 AT E529440T1 AT 08006914 T AT08006914 T AT 08006914T AT 08006914 T AT08006914 T AT 08006914T AT E529440 T1 ATE529440 T1 AT E529440T1
- Authority
- AT
- Austria
- Prior art keywords
- peptide
- active ingredient
- containing same
- ingredient containing
- seq
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 239000004480 active ingredient Substances 0.000 title abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 3
- 210000001185 bone marrow Anatomy 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000024245 cell differentiation Effects 0.000 abstract 1
- 230000010261 cell growth Effects 0.000 abstract 1
- 210000000250 cementoblast Anatomy 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 210000001612 chondrocyte Anatomy 0.000 abstract 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 abstract 1
- 210000000963 osteoblast Anatomy 0.000 abstract 1
- 210000002379 periodontal ligament Anatomy 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003045166 | 2003-02-21 | ||
| JP2003142845A JP2004307454A (ja) | 2003-02-21 | 2003-05-21 | 生理活性ペプチド及びこれを含有する薬剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE529440T1 true ATE529440T1 (de) | 2011-11-15 |
Family
ID=32911432
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08006914T ATE529440T1 (de) | 2003-02-21 | 2004-02-20 | Biologisch aktives peptid und wirkstoff, der dieses enthält |
| AT04713248T ATE466025T1 (de) | 2003-02-21 | 2004-02-20 | Physiologisch aktive peptide und medikamente, die diese enthalten |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04713248T ATE466025T1 (de) | 2003-02-21 | 2004-02-20 | Physiologisch aktive peptide und medikamente, die diese enthalten |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7365153B2 (de) |
| EP (2) | EP2000478B1 (de) |
| JP (3) | JP2004307454A (de) |
| AT (2) | ATE529440T1 (de) |
| DE (1) | DE602004026840D1 (de) |
| ES (2) | ES2347245T3 (de) |
| WO (1) | WO2004074319A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004307454A (ja) * | 2003-02-21 | 2004-11-04 | Seikagaku Kogyo Co Ltd | 生理活性ペプチド及びこれを含有する薬剤 |
| US8707326B2 (en) * | 2012-07-17 | 2014-04-22 | Concurix Corporation | Pattern matching process scheduler in message passing environment |
| US9575813B2 (en) | 2012-07-17 | 2017-02-21 | Microsoft Technology Licensing, Llc | Pattern matching process scheduler with upstream optimization |
| CN119241640B (zh) * | 2024-12-06 | 2025-04-25 | 杭州康源食品科技有限公司 | 一种促进骨骼生长的三肽 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU715247B2 (en) | 1995-07-13 | 2000-01-20 | Biora Ab | Enamel matrix related polypeptide |
| US6300062B1 (en) * | 1995-07-13 | 2001-10-09 | Biora Ab | Enamel matrix related polypeptide |
| US20010039335A1 (en) * | 1997-04-10 | 2001-11-08 | Kenneth Jacobs | Secreted proteins and polynucleotides encoding them |
| CA2316973A1 (en) | 1998-01-07 | 1999-07-15 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
| EP1059934B1 (de) * | 1998-02-27 | 2002-07-24 | Biora Bioex AB | Matrixprotein enthaltende zusammensetzungen zur wundheilung |
| US6503539B2 (en) * | 1998-02-27 | 2003-01-07 | Biora Bioex Ab | Matrix protein compositions for wound healing |
| ES2215028T3 (es) * | 1999-03-10 | 2004-10-01 | Biora Bioex Ab | Composiciones de proteinas de matrices destinadas para el injertado en tejidos no mineralizados. |
| CN1302883A (zh) * | 1999-10-29 | 2001-07-11 | 上海博道基因技术有限公司 | 一种新的多肽——人成釉质蛋白23和编码这种多肽的多核苷酸 |
| JP2004307454A (ja) * | 2003-02-21 | 2004-11-04 | Seikagaku Kogyo Co Ltd | 生理活性ペプチド及びこれを含有する薬剤 |
-
2003
- 2003-05-21 JP JP2003142845A patent/JP2004307454A/ja active Pending
-
2004
- 2004-02-20 US US10/546,223 patent/US7365153B2/en not_active Expired - Fee Related
- 2004-02-20 EP EP08006914A patent/EP2000478B1/de not_active Expired - Lifetime
- 2004-02-20 JP JP2005502796A patent/JP4630816B2/ja not_active Expired - Fee Related
- 2004-02-20 EP EP04713248A patent/EP1602665B1/de not_active Expired - Lifetime
- 2004-02-20 ES ES04713248T patent/ES2347245T3/es not_active Expired - Lifetime
- 2004-02-20 WO PCT/JP2004/002009 patent/WO2004074319A1/ja not_active Ceased
- 2004-02-20 AT AT08006914T patent/ATE529440T1/de not_active IP Right Cessation
- 2004-02-20 ES ES08006914T patent/ES2378711T3/es not_active Expired - Lifetime
- 2004-02-20 DE DE602004026840T patent/DE602004026840D1/de not_active Expired - Lifetime
- 2004-02-20 AT AT04713248T patent/ATE466025T1/de not_active IP Right Cessation
-
2008
- 2008-03-20 US US12/052,578 patent/US7678884B2/en not_active Expired - Fee Related
-
2010
- 2010-03-23 JP JP2010066733A patent/JP5047323B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2347245T3 (es) | 2010-10-27 |
| ATE466025T1 (de) | 2010-05-15 |
| WO2004074319A1 (ja) | 2004-09-02 |
| US7678884B2 (en) | 2010-03-16 |
| JP2004307454A (ja) | 2004-11-04 |
| EP1602665A1 (de) | 2005-12-07 |
| JP5047323B2 (ja) | 2012-10-10 |
| EP2000478B1 (de) | 2011-10-19 |
| DE602004026840D1 (de) | 2010-06-10 |
| ES2378711T3 (es) | 2012-04-17 |
| US20090137482A1 (en) | 2009-05-28 |
| EP2000478A1 (de) | 2008-12-10 |
| US7365153B2 (en) | 2008-04-29 |
| JP2010189399A (ja) | 2010-09-02 |
| US20060172947A1 (en) | 2006-08-03 |
| JP4630816B2 (ja) | 2011-02-09 |
| JPWO2004074319A1 (ja) | 2006-06-01 |
| EP1602665B1 (de) | 2010-04-28 |
| EP1602665A4 (de) | 2007-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE494904T1 (de) | Verbindungen und verfahren zur erhöhung der neurogenese | |
| BR0111718A (pt) | Peptìdeos quimicamente modificados, composições e métodos de produção e uso | |
| IL150223A (en) | Lipopeptides and pharmaceuticals containing them | |
| SV1996000033A (es) | Isotiazolonas | |
| ATE432291T1 (de) | Kdr-peptide und diese enthaltende impfstoffe | |
| MXPA02006028A (es) | Lipopeptidos novedosos como agentes antibacterianos. | |
| ATE496060T1 (de) | Proteinartige verbindungen und anwendungen davon | |
| DE60133802D1 (de) | Verwendung von säurestabilen proteasen in tierfutter | |
| AR036196A1 (es) | Agentes de contraste multimericos dirigidos a base de peptidos | |
| AR023130A1 (es) | Composiciones para promover el crecimiento | |
| ATE481987T1 (de) | Verfahren zur radiofluoridierung von biologisch aktiven vektoren | |
| MXPA02006030A (es) | Lipopeptidos como agentes antibacterianos. | |
| ATE382685T1 (de) | Bakteriophagen-lysin | |
| NO20020176L (no) | Sykliske peptidderivater som inhibitorer for intergrin <alfa>v<beta>6 | |
| DE60234822D1 (de) | Lipoxygenase-varianten und ihre verwendung | |
| AR021695A1 (es) | 4,5-pirazinoxindoles, composicion farmaceutica y uso | |
| PL1555260T3 (pl) | Związki fenylotetrazolu | |
| ATE529440T1 (de) | Biologisch aktives peptid und wirkstoff, der dieses enthält | |
| DE69735039D1 (de) | Acetylhydrolase des Plättchen aktivierenden Faktors, und entsprechendes Gen | |
| DE69333351D1 (de) | Rekombinante lipase aus hundemagen und pharmazeutische zusammensetzungen | |
| ATE441713T1 (de) | Tumorantigenprotein und dessen verwendung | |
| DE60135489D1 (de) | Lactam dipeptid und dessen verwendung zur inhibierung der beta-amyloid peptid frisetzung | |
| PE20050356A1 (es) | Preparacion de peptidos de somatostatina | |
| EP1074264A4 (de) | Inhibitoren für die gefässneubildung | |
| DE68925540D1 (de) | Peptid-Antibiotika |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |